{"id":404107,"date":"2026-03-10T14:40:00","date_gmt":"2026-03-10T14:40:00","guid":{"rendered":"https:\/\/dailybanglanewspapers.com\/news\/coloplast-a-s-allocation-of-share-options\/"},"modified":"2026-03-10T14:40:00","modified_gmt":"2026-03-10T14:40:00","slug":"coloplast-a-s-allocation-of-share-options","status":"publish","type":"post","link":"https:\/\/dailybanglanewspapers.com\/news\/coloplast-a-s-allocation-of-share-options\/","title":{"rendered":"Coloplast A\/S – Allocation of Share Options"},"content":{"rendered":"

<\/p>\n

\n

Report on transactions of executives and related parties in Coloplast shares and related securities<\/strong><\/p>\n

According to the Market Abuse Regulation article 19 Coloplast is obliged to report on the transactions of executives and their related parties in Coloplast shares and related securities.<\/p>\n

The below transactions concern allocation of share options.<\/p>\n

For further details, reference is made to Coloplast\u2019s Remuneration Policy. The policy is available on the group website at this address:<\/p>\n

Policies and positions<\/a><\/p>\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n\n
\u00a0<\/td>\nDetails of the person discharging managerial responsibilities\/person closely associated<\/b> <\/td>\n<\/tr>\n
a)<\/td>\nName<\/td>\nLars Rasmussen<\/i><\/td>\n<\/tr>\n
2<\/b><\/td>\nReason for the notification<\/b> <\/td>\n<\/tr>\n
a)<\/td>\nPosition\/status<\/td>\nInterim President & CEO<\/i><\/td>\n<\/tr>\n
b)<\/td>\nInitial notification\/Amendment<\/td>\nInitial notification<\/i> <\/td>\n<\/tr>\n
3<\/b><\/td>\nDetails of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor<\/b> <\/td>\n<\/tr>\n
a)<\/td>\nName<\/td>\nColoplast A\/S (CVR-no.: 69749917)<\/i><\/td>\n<\/tr>\n
b)<\/td>\nLEI<\/td>\n529900NN7SOJ5QG82X67<\/i><\/td>\n<\/tr>\n
4<\/b><\/td>\nDetails of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted<\/b> <\/td>\n<\/tr>\n
a)<\/td>\nDescription of the financial instrument, type of instrument <\/td>\nShare options relating to B shares <\/i><\/td>\n<\/tr>\n
Identification code<\/td>\nISIN: DK0060448595 (B shares)<\/i><\/td>\n<\/tr>\n
b)<\/td>\nNature of the transaction<\/td>\nShare option allocation<\/i><\/td>\n<\/tr>\n
c)<\/td>\nPrice and volume<\/td>\nPrice<\/td>\nVolume<\/td>\n<\/tr>\n
0.00\u00a0\u00a0<\/i><\/td>\n33,897\u00a0\u00a0<\/i><\/td>\n<\/tr>\n
d)<\/td>\nAggregated information<\/td>\n\u00a0<\/i><\/td>\n<\/tr>\n
–\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Aggregated volume<\/td>\n33,897 <\/i>share options<\/i><\/td>\n<\/tr>\n
–\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Price<\/td>\nDKK 0.00<\/i><\/td>\n<\/tr>\n
e)<\/td>\nDate of the transaction<\/td>\n2026-03-10, 09:00 UTC<\/i><\/td>\n<\/tr>\n
f)<\/td>\nPlace of the transaction<\/td>\nOutside a trading venue<\/i><\/td>\n<\/tr>\n
1<\/b><\/td>\nDetails of the person discharging managerial responsibilities\/person closely associated<\/b> <\/td>\n<\/tr>\n
a)<\/td>\nName<\/td>\nAnders Lonning-Skovgaard<\/i><\/td>\n<\/tr>\n
2<\/b><\/td>\nReason for the notification<\/b> <\/td>\n<\/tr>\n
a)<\/td>\nPosition\/status<\/td>\nExecutive Vice President & CFO<\/i><\/td>\n<\/tr>\n
b)<\/td>\nInitial notification\/Amendment<\/td>\nInitial notification<\/i> <\/td>\n<\/tr>\n
3<\/b><\/td>\nDetails of the issuer, emission allowance market participant, auction platform, auctioneer, or auction monitor<\/b> <\/td>\n<\/tr>\n
a)<\/td>\nName<\/td>\nColoplast A\/S (CVR-no.: 69749917)<\/i><\/td>\n<\/tr>\n
b)<\/td>\nLEI<\/td>\n529900NN7SOJ5QG82X67<\/i><\/td>\n<\/tr>\n
4<\/b><\/td>\nDetails of the transaction(s): section to be repeated for (i) each type of instrument; (ii) each type of transaction; (iii) each date; and (iv) each place where transactions have been conducted<\/b> <\/td>\n<\/tr>\n
a)<\/td>\nDescription of the financial instrument, type of instrument <\/td>\nShare options relating to B shares <\/i><\/td>\n<\/tr>\n
Identification code<\/td>\nISIN: DK0060448595 (B shares)<\/i><\/td>\n<\/tr>\n
b)<\/td>\nNature of the transaction<\/td>\nShare option allocation<\/i><\/td>\n<\/tr>\n
c)<\/td>\nPrice and volume<\/td>\nPrice<\/td>\nVolume<\/td>\n<\/tr>\n
0.00\u00a0\u00a0<\/i><\/td>\n43,134\u00a0\u00a0<\/i><\/td>\n<\/tr>\n
d)<\/td>\nAggregated information<\/td>\n\u00a0<\/i><\/td>\n<\/tr>\n
–\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Aggregated volume<\/td>\n43,134 <\/i>share options<\/i><\/td>\n<\/tr>\n
–\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0\u00a0 Price<\/td>\nDKK 0.00<\/i><\/td>\n<\/tr>\n
e)<\/td>\nDate of the transaction<\/td>\n2026-03-10, 09:00 UTC<\/i><\/td>\n<\/tr>\n
f)<\/td>\nPlace of the transaction<\/td>\nOutside a trading venue<\/i><\/td>\n<\/tr>\n<\/table>\n

For further information, please contact
<\/b><\/p>\n

Investors and analysts<\/i><\/b>
Anders Lonning-Skovgaard
Executive Vice President, CFO
Tel. +45 4911 1111 <\/p>\n

Kristine Husted Munk
Senior Director, Investor Relations
Tel. +45 4911 1800 \/ +45 4911 3266
Email: dkkhu@coloplast.com<\/p>\n

Simone Dyrby Helvind
Senior Manager, Investor Relations
Tel. +45 4911 1800 \/ +45 4911 2981
Email: dkkhu@coloplast.com<\/p>\n

Press and media<\/i><\/b>
Peter M\u00f8nster
Head of Media Relations & Corporate Content
Tel. +45 4911 2623
Email: dkpete@coloplast.com<\/p>\n

Address<\/i><\/b>
Coloplast A\/S
Holtedam 1
DK-3050 Humlebaek
Denmark
Company reg. (CVR) no. 69749917<\/p>\n

Website<\/i><\/b>
www.coloplast.com<\/a><\/p>\n

This announcement is available in a Danish and an English-language version. In the event of discrepancies, the English version shall prevail.<\/p>\n

The Coloplast story begins back in 1954. Elise S\u00f8rensen is a nurse. Her sister Thora has just had an ostomy operation and is afraid to go out in public, fearing that her stoma might leak. Listening to her sister\u2019s problems, Elise conceives the idea of the world\u2019s first adhesive ostomy bag. Based on Elise\u2019s idea, Aage Louis-Hansen, a civil engineer and plastics manufacturer, and his wife Johanne Louis-Hansen, a trained nurse, created the ostomy bag. A bag that does not leak, giving Thora \u2013 and thousands of people like her \u2013 the chance to live the life they want.
A simple solution that makes a difference.<\/p>\n

Today, the Coloplast Group develops products and services that help millions of people live more independent lives through solutions tailored to their needs. Globally, our business areas include Ostomy Care, Continence Care, Voice & Respiratory Care, Wound & Tissue Repair, and Interventional Urology.<\/p>\n

The Coloplast logo is a registered trademark of Coloplast A\/S. \u00a9 2026-03.<\/p>\n

All rights reserved Coloplast A\/S, 3050 Humlebaek, Denmark.<\/p>\n

Please see enclosed pdf.<\/p>\n